The FDA has notified healthcare professionals that it is requiring the manufacturers of licensed botulinum toxin products, including Botox and Botox Cosmetic (botulinum toxin type A, from Allergan) ...

Early Communication about an Ongoing Safety Review Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) This information reflects FDA’s current analysis of ...

Health Canada, the federal agency, has announced it is reviewing the safety of the wrinkle treatment Botox and of a similar drug called Myobloc. The move comes only days after a call from a U.S. lobby ...

LOUISVILLE, Ky., Aug. 26, 2019 /PRNewswire/ -- US WorldMeds, LLC announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (sBLA) for ...

Elan has sold its worldwide rights to Myobloc, a drug treatment for chronic back and neck pain. Myobloc was developed by Elan and is currently approved in the US, Canada and Europe for the treatment ...

A consumer group on Thursday called for Irvine-based Allergan Inc.’s Botox and a similar drug to be labeled with a “black box” warning after reports of 16 deaths and other problems after the main ...

Order Your Report Now For A Swift Delivery: What Is the Future Outlook for the Myobloc Market? The Myobloc market is expected to continue expanding, with projections ...

Myobloc market Report 2025 – Market Size, Trends, And Forecast 2025-2034 The Business Research Company's Myobloc Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Updated 2025 ...